Clinical Trial Detail

NCT ID NCT02126579
Title Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Craig L Slingluff, Jr
Indications

melanoma

Therapies

Poly ICLC

Long peptide vaccine 7

Age Groups: adult

No variant requirements are available.